SUMMARY
This is a combination product containing Carisoprodol, a centrally-acting muscle relaxant, plus aspirin, an analgesic with antipyretic and anti-inflammatory properties. It is available as a two layered, white and light lavender round tablet for oral administration.
Carisoprodol and Aspirin Tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of pain, muscle spasm, and limited mobility associated with acute, painful musculoskeletal conditions.
|
NEWS HIGHLIGHTS RELATED TO CARISOPRODOL AND ASPIRIN
Media Articles Related to Carisoprodol and Aspirin (Carisoprodol / Aspirin)
EonC, The First Extended-Life Primary Cell Neurostimulator For The Treatment Of Chronic Pain Approved In USA And Europe Source: Pain / Anesthetics News From Medical News Today [2008.08.18]
International Association For The Study Of Pain 12th World Congress - Race Against Pain Launch Source: Pain / Anesthetics News From Medical News Today [2008.08.18]
Knee Pain Source: MedicineNet Knee Bursitis Specialty [2008.08.18]
New Mothers Speak Out Report Paints A Troubling Picture Of American Women In Postpartum Period Source: Pregnancy / Obstetrics News From Medical News Today [2008.08.17]
Prescription Drug Therapy Often As Effective As Costly Angioplasty In Treating Non-Emergency Patients With Chronic Chest Pain, Study Finds Source: Cardiovascular / Cardiology News From Medical News Today [2008.08.15]
Clinical Trials Related to Carisoprodol and Aspirin (Carisoprodol / Aspirin)
Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis [Completed]
17-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer
|